APA (7th ed.) Citation

Gezelius, E., & Krämer, R. (2019). Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN). European journal of cancer, 118, . https://doi.org/10.1016/j.ejca.2019.06.015

Chicago Style (17th ed.) Citation

Gezelius, Emelie, and Roland Krämer. "Low-molecular-weight Heparin Adherence and Effects on Survival Within a Randomised Phase III Lung Cancer Trial (RASTEN)." European Journal of Cancer 118 (2019). https://doi.org/10.1016/j.ejca.2019.06.015.

MLA (9th ed.) Citation

Gezelius, Emelie, and Roland Krämer. "Low-molecular-weight Heparin Adherence and Effects on Survival Within a Randomised Phase III Lung Cancer Trial (RASTEN)." European Journal of Cancer, vol. 118, 2019, https://doi.org/10.1016/j.ejca.2019.06.015.